Assignee
ZHU ZHENGLUN
US·8 granted patents·13 pending applications·5 citations·filing 2007–2024
Top patents by PatentIndex Score
21 records- 0182US11248252B2Treatment and diagnosis of immune disordersZHU ZHENGLUN·Filed 2018·Granted Feb 15, 2022·1 cites·9 claims
- 0282US2025019763A1Homeobox transcription factor ventx regulates differentiation and maturation of human dendritic cellsZHU ZHENGLUN·Filed 2024·Application pending·0 cites
- 0382US2025188474A1Treatment and diagnosis of inflammatory disordersZHU ZHENGLUN·Filed 2024·Application pending·0 cites
- 0482US2025235512A1Method of modifying macrophage differentiation and immunityZHU ZHENGLUN·Filed 2024·Application pending·0 cites
- 0580US11268095B2Treatment and diagnosis of inflammatory disordersZHU ZHENGLUN·Filed 2017·Granted Mar 8, 2022·1 cites·4 claims
- 0680US2025281616A1Methods for treating neoplastic diseasesZHU ZHENGLUN·Filed 2024·Application pending·0 cites
- 0777US2024374638A1Methods for treating neoplastic diseasesZHU ZHENGLUN·Filed 2024·Application pending·0 cites
- 0876US12146138B2Treatment and diagnosis of inflammatory disordersZHU ZHENGLUN·Filed 2022·Granted Nov 19, 2024·0 cites·7 claims
- 0976US7994126B2Treatment of cellular proliferative disorders with compositions comprising Hom polypeptide (also known as Xom, VENTX2)ZHU ZHENGLUN·Filed 2007·Granted Aug 9, 2011·2 cites·11 claims
- 1074US2024132935A1Treatment and diagnosis of immune disordersZHU ZHENGLUN·Filed 2022·Application pending·0 cites
- 1170US8741865B2Treatment of immune disorders with Hom-1 inhibitorsZHU ZHENGLUN·Filed 2010·Granted Jun 3, 2014·1 cites·9 claims
- 1269US2021393682A1Method of modifying macrophage differentiation and immunityZHU ZHENGLUN·Filed 2021·Application pending·0 cites
- 1369US2020224272A1Homeobox transcription factor ventx regulates differentiation and maturation of human dendritic cellsZHU ZHENGLUN·Filed 2019·Application pending·0 cites
- 1467US2020023006A1Methods for treating neoplastic diseasesZHU ZHENGLUN·Filed 2019·Application pending·0 cites
- 1560US10544460B2Homeobox transcription factor ventx regulates differentiation and maturation of human dendritic cellsZHU ZHENGLUN·Filed 2014·Granted Jan 28, 2020·0 cites·2 claims
- 1659US2025283050A1Method of cancer treatmentZHU ZHENGLUN·Filed 2022·Application pending·0 cites
- 1759US2014315205A1Treatment and diagnosis of immune disordersZHU ZHENGLUN·Filed 2014·Application pending·0 cites
- 1858US8993227B2Cancer prognosis by determining phosphorylation of a Xom polypeptideZHU ZHENGLUN·Filed 2013·Granted Mar 31, 2015·0 cites·15 claims
- 1958US2018325949A1Method of modifying macrophage differentiation and immunityZHU ZHENGLUN·Filed 2016·Application pending·0 cites
- 2049US2011300549A1Treatment of Development-Related DisordersZHU ZHENGLUN·Filed 2011·Application pending·0 cites
- 2141US10066272B2Human homeobox gene ventx and macrophage terminal differentiation and activation, compositions and methods thereofZHU ZHENGLUN·Filed 2012·Granted Sep 4, 2018·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when ZHU ZHENGLUN files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →